CClinicalTrials.gg
CompletedNCT01270269ACT-ICUUpdated Mar 3, 2017

ACT-ICU Study: Activity and Cognitive Therapy in the Intensive Care Unit

An interventional study of Behavioral: Physical and functional rehabilitation and Behavioral: Cognitive, physical, & functional rehabilitation in Brain Injuries, Dementia and Myopathies, sponsored by Vanderbilt University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-03-03.

Sponsored by Vanderbilt University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
87
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Intensive care unit (ICU) hospitalization saves lives but often does so at a high personal cost to ICU survivors who frequently experience significant cognitive impairment and an array of physical and functional disabilities that limit their recovery and quality of life. While the problems experienced by these patients are likely amenable to rehabilitation, few ICU survivors receive focused rehabilitation. Recently, early physical rehabilitation in ICU patients has shown to improve the chances a patient will regain their pre-hospital functional status. Early cognitive rehabilitation for these patients has not yet been explored. This pilot study will determine the feasibility of early cognitive rehabilitation in ICU patients. The investigators will perform cognitive and physical rehabilitation, beginning in the earliest phases of critical illness, to determine the effect of these therapies on cognitive and functional outcomes in ICU survivors. The investigators hypothesize that combined cognitive and physical rehabilitation, started in the ICU, will improve recovery of cognitive and physical function as well as improve quality of life of ICU survivors.

Read the detailed description

The long-term consequences of critical illness and intensive care unit (ICU) hospitalization in ICU survivors are profound and include cognitive, physical, and functional impairments. The purpose of this study is to pilot test a multi-component, cognitive and physical rehabilitation program beginning in the ICU, combined with a 12-week home-based cognitive rehabilitation program following hospital discharge to determine whether participation in a rehabilitation program will result in improved outcomes among ICU survivors. The study will rely on a randomized controlled clinical trial design, with patients assigned to one of three groups: a "usual care" control group, an early physical activity group (without cognitive therapy), or an early cognitive therapy and physical activity group. All individuals in the intervention groups will receive protocolized physical therapy while hospitalized. In addition, individuals in the early cognitive therapy and physical activity group will receive cognitive therapy starting in the ICU and continuing for 12 weeks once a patient leaves the hospital. In-home visits will occur every other week during the 12-week intervention period.

The study's primary outcome is executive functioning (e.g. ability to plan, organize, multi-task) at 3-months following hospital discharge as measured by the Tower Test, a psychometric tool evaluating executive abilities. This has been chosen due to the fact that available research points to the presence of significant deficits in executive functioning among ICU survivors. Secondary outcomes include global cognitive function, physical function and Health Related Quality of Life by assessing scores on the following measures: Katz's ADL, Functional Activities Questionnaire, AD8, Short-Informant Questionnaire of Cognitive Decline in the Elderly, Clinical Dementia Rating Scale (if performed), Timed Up \& Go test, Mini-Mental State Exam, Dysexecutive Questionnaire, Activities-Specific Balance Confidence Scale, Behavior Rating Inventory of Executive Function, Behavior Pain Inventory, Trails A \& B test, Repeatable Battery for Assessment of Neuropsychological Status, General Employment Questionnaire, Beck Depression Inventory II, Post-traumatic stress checklist, Short Form 36, Canadian Study of Health and Aging and patient weight, and Tower Test score at 12 month follow-up. We will also track readmission to the hospital and admission to a nursing home or skilled rehabilitation facility as secondary outcomes during the 12-month follow-up period. The study duration will include 1 year of enrollment and 1 year for study completion following enrollment of the final patient.

02

Conditions studied

  • Brain Injuries
  • Dementia
  • Myopathies
  • Muscle Disorders

Keywords

  • Asthenia
  • Muscle Weakness
  • Brain Injuries
  • Critical Illness
  • Critical Illness Myoneuropathy
  • Rehabilitation
  • Sepsis
  • Respiratory Failure
  • Delirium
  • Over-sedation
  • Immobility
  • Aging
  • Signs and Symptoms
  • Muscular Diseases
  • Musculoskeletal Diseases
  • Neuromuscular Manifestations
  • Neurologic Manifestations
  • Pathologic Processes
  • Brain Diseases
  • Central Nervous System Diseases
  • Craniocerebral Trauma
  • Trauma, Nervous System
  • Wounds and Injuries
  • Disorders of Environmental Origin
03

In context

Muscular Diseases

280 studies on the registry are indexed under Muscular Diseases; 63 are open to participants now.

This study's enrollment of 87 is above the median of 34 across 157 interventional studies indexed under Muscular Diseases.

Browse Muscular Diseases studies →

Lead sponsor

Vanderbilt University is the lead sponsor of 508 studies on the registry; 19 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 5 (71%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adult patients admitted to the medical or surgical ICU who are receiving treatment for respiratory failure, cardiogenic shock, hemorrhagic shock, and/or septic shock.

Exclusion criteria

Exclusion Criteria:

  • Moderate to severe dementia on ICU admission based on a standardized surrogate assessment (as this would prohibit patients from functioning independently at home);
  • Moderate or severe physical dysfunction that precludes performance of independent activities of daily living based on a standardized surrogate assessment;
  • Live greater than 120 miles from Nashville;
  • Blind, deaf, or unable to speak English;
  • Prisoners;
  • Homelessness and no secondary contact person available
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
87 participants (actual)

Study arms

  • No intervention
    Patients (Controls)

    Patients (Controls) will not receive formal (study-related) rehabilitation interventions and will only receive usual care.

  • Experimental
    Behavioral: Phys & Func Rehab

    A multi-component program of physical rehabilitation interventions (without cognitive rehabilitation) will be delivered to patients beginning in the ICU and continue throughout the hospitalization.

    Behavioral: Behavioral: Physical and functional rehabilitation

  • Experimental
    Behavioral: Cog/Phys/Func Rehab

    A multi-component program of cognitive, physical, and functional rehabilitation interventions will be delivered to patients beginning in the ICU with continued cognitive rehabilitation in their home environments over a focused 12-week period.

    Behavioral: Behavioral: Cognitive, physical, & functional rehabilitation

Interventions

  • BehavioralBehavioral: Physical and functional rehabilitation

    A multi-component program of physical rehabilitation interventions (without cognitive rehabilitation) will be delivered to patients beginning in the ICU and continue throughout the hospitalization.

    Also known as: cognitive rehabilitation

  • BehavioralBehavioral: Cognitive, physical, & functional rehabilitation

    A multi-component program of cognitive, physical, and functional rehabilitation interventions will be delivered to patients beginning in the ICU with continued cognitive rehabilitation in their home environments over a focused 12-week period.

    Also known as: cognitive rehabilitation

06

What researchers measure

Primary outcomes

  1. Tower Test

    A psychometric measure of executive functioning.

    Time frame: 3 months post hospital discharge

Secondary outcomes

  1. Timed Up and Go (TUG)

    A timed test assessing physical strength and gait speed.

    Time frame: 3 months post hospital discharge

  2. Functional Activities Questionnaire

    A brief measure of higher order (IADL) functioning.

    Time frame: 3 months post hospital discharge

  3. EQ-5 Global Scores

    The EQ-5 Global Scores is an assessment of quality of life.

    Time frame: 3 months post hospital discharge

  4. Katz Activities of Daily Living (ADL) scale

    A six-item tool assessing the degree of independence vs. dependence in basic activities of daily living.

    Time frame: 3 months post hospital discharge

  5. Activities-Specific Balance Confidence Scale (ABC)

    A brief rating scale that asks participants to rate how confident they are that they can maintain their balance and remain steady while engaged in 16 non-hazardous tasks.

    Time frame: 3 months post hospital discharge

  6. AD8

    A brief surrogate or patient based measure that assesses recent change in a variety of cognitive abilities.

    Time frame: 3 months post hospital discharge

  7. Short-Informant Questionnaire of Cognitive Decline in the Elderly (Short IQCODE)

    A measure of cognitive functioning that evaluates the degree of decline from baseline and which is complementary to the AD8. This measure will only be used in patients over the age of 50 who had any problems with memory or thinking prior to current illness.

    Time frame: 3 months post hospital discharge

  8. Mini Mental State Exam (MMSE)

    A widely used measure of overall cognitive functioning that briefly samples abilities in a wide array of areas including memory and attention.

    Time frame: 3 months post hospital discharge

  9. Dysexecutive Questionnaire (Dys Exec)

    A questionnaire, which has both patient and surrogate versions, that assesses patient functioning in a number of functional areas sensitive to executive dysfunction.

    Time frame: 3 months post hospital discharge

  10. TRAILS A & B Test

    Two widely used to test the speed that it takes to connect a series of numbers (Part A) and numbers alternating with letters (Part B).

    Time frame: 3 months post hospital discharge

  11. General and Employment Questionnaire

    A brief series of questions which pertain to patient history and demographics and which also inquire about employment both before and after ICU hospitalization.

    Time frame: 3 months post hospital discharge

  12. Canadian Study of Health and Aging (CHSA) Frailty Scale

    A brief global rating scale of frailty based on clinical impression.

    Time frame: 3 months post hospital discharge

  13. Tower Test

    A psychometric measure of executive functioning.

    Time frame: 12 months post hospital discharge

  14. Timed Up and Go (TUG)

    A timed test assessing physical strength and gait speed.

    Time frame: 12 months post hospital discharge

  15. Functional Activities Questionnaire

    A brief measure of higher order (IADL) functioning.

    Time frame: 12 months post-hospital discharge

  16. EQ-5 Global Scores

    The EQ-5 Global Scores is an assessment of quality of life.

    Time frame: 12 months post hospital discharge

  17. Katz Activities of Daily Living (ADL) scale

    A six-item tool assessing the degree of independence vs. dependence in basic activities of daily living.

    Time frame: 12 months post hospital discharge

  18. Activities-Specific Balance Confidence Scale (ABC)

    A brief rating scale that asks participants to rate how confident they are that they can maintain their balance and remain steady while engaged in 16 non-hazardous tasks.

    Time frame: 12 months post hospital discharge

  19. AD8

    A brief surrogate or patient based measure that assesses recent change in a variety of cognitive abilities.

    Time frame: 12 months post hospital discharge

  20. Short-Informant Questionnaire of Cognitive Decline in the Elderly (Short IQCODE)

    A measure of cognitive functioning that evaluates the degree of decline from baseline and which is complementary to the AD8. This measure will only be used in patients over the age of 50 who had any problems with memory or thinking prior to current illness.

    Time frame: 12 months post hospital discharge

  21. Mini Mental State Exam (MMSE)

    A widely used measure of overall cognitive functioning that briefly samples abilities in a wide array of areas including memory and attention.

    Time frame: 12 months post hospital discharge

  22. Dysexecutive Questionnaire (Dys Exec)

    A questionnaire, which has both patient and surrogate versions, that assesses patient functioning in a number of functional areas sensitive to executive dysfunction.

    Time frame: 12 months post hospital discharge

  23. TRAILS A & B Test

    Two widely used to test the speed that it takes to connect a series of numbers (Part A) and numbers alternating with letters (Part B).

    Time frame: 12 months post hospital discharge

  24. General and Employment Questionnaire

    A brief series of questions which pertain to patient history and demographics and which also inquire about employment both before and after ICU hospitalization.

    Time frame: 12 months post hospital discharge

  25. Canadian Study of Health and Aging (CHSA) Frailty Scale

    A brief global rating scale of frailty based on clinical impression.

    Time frame: 12 months post hospital discharge

  26. Mortality

    Time frame: 2 months post hospital discharge

  27. Rehospitalization rate and number of hospital days

    Time frame: 12 months post hospital discharge

07

Study locations

1 site
  • Vanderbilt University Medical Center
    Nashville, Tennessee 37232, United States
08

References and documents

Publications

  • Schweickert WD, Herlitz J, Pohlman AS, Gehlbach BK, Hall JB, Kress JP. A randomized, controlled trial evaluating postinsertion neck ultrasound in peripherally inserted central catheter procedures. Crit Care Med. 2009 Apr;37(4):1217-21. doi: 10.1097/CCM.0b013e31819cee7f. PubMed 19242336 ↗
  • Brummel NE, Jackson JC, Girard TD, Pandharipande PP, Schiro E, Work B, Pun BT, Boehm L, Gill TM, Ely EW. A combined early cognitive and physical rehabilitation program for people who are critically ill: the activity and cognitive therapy in the intensive care unit (ACT-ICU) trial. Phys Ther. 2012 Dec;92(12):1580-92. doi: 10.2522/ptj.20110414. Epub 2012 May 10. PubMed 22577067 ↗
  • Jackson JC, Ely EW, Morey MC, Anderson VM, Denne LB, Clune J, Siebert CS, Archer KR, Torres R, Janz D, Schiro E, Jones J, Shintani AK, Levine B, Pun BT, Thompson J, Brummel NE, Hoenig H. Cognitive and physical rehabilitation of intensive care unit survivors: results of the RETURN randomized controlled pilot investigation. Crit Care Med. 2012 Apr;40(4):1088-97. doi: 10.1097/CCM.0b013e3182373115. PubMed 22080631 ↗
  • Brummel NE, Girard TD, Ely EW, Pandharipande PP, Morandi A, Hughes CG, Graves AJ, Shintani A, Murphy E, Work B, Pun BT, Boehm L, Gill TM, Dittus RS, Jackson JC. Feasibility and safety of early combined cognitive and physical therapy for critically ill medical and surgical patients: the Activity and Cognitive Therapy in ICU (ACT-ICU) trial. Intensive Care Med. 2014 Mar;40(3):370-9. doi: 10.1007/s00134-013-3136-0. Epub 2013 Nov 21. PubMed 24257969 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 3, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01270269
Lead sponsor
Vanderbilt University
Collaborators
Vanderbilt University Medical Center
Responsible party
Nathan Brummel (Assistant Professor of Medicine, Vanderbilt University) — Principal investigator
First posted
Jan 5, 2011
Start date
Feb 2011
Primary completion
Mar 2013
Completion
Jun 2014
Last update
Mar 3, 2017

Study contacts

Nathan E. Brummel, MD
principal investigator · Vanderbilt University School of Medicine

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion